Clinical Trials Logo

Clinical Trial Summary

This protocol is designed to investigate the use of novel techniques in MRI that may not yet be commercially available. Specifically, the protocol enables patients to take advantage of new pulse sequence software, coil design or post processing capabilities not otherwise available. The informed consent explains MRI in lay terms, describes the use of contrast agents and lists contraindications to MRI.


Clinical Trial Description

NMR imaging promises to provide useful and unique diagnostic information in a variety of diseases. In an attempt to evaluate its role, we plan to study a wide range of diseases during the initial year of imaging. Exposure to magnetic fields and radiofrequency energies of this magnitude have demonstrated no deleterious effects clinically or in the laboratory. The only restrictions will be those imposed by ferromagnetic objects within the patient which would increase the risk of placing them in a strong magnetic field. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00001194
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date April 1984
Completion date February 2001

See also
  Status Clinical Trial Phase
Completed NCT01415414 - Observational Study of Ultravist in Patients Requiring CECT N/A
Terminated NCT00975299 - Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Not yet recruiting NCT05036460 - Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients N/A
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Completed NCT01009359 - Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers Phase 1
Completed NCT00244140 - Ultravist: Safety and Efficacy in Computed Tomography of Head and Body Phase 3
Completed NCT02980081 - Abdominal Plain X-ray in the Emergency Departement N/A
Completed NCT01205321 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Recruiting NCT05823857 - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain N/A
Recruiting NCT04859634 - Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Completed NCT03125629 - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Phase 2
Terminated NCT03167190 - Ultrasound-Assisted Lumbar Puncture N/A
Completed NCT01297088 - PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. Phase 1
Completed NCT01089998 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations Phase 1
Completed NCT00347022 - A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications Phase 4
Completed NCT00876083 - PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination N/A
Completed NCT01411449 - Primovist Post-marketing Surveillance in Japan N/A
Completed NCT01153607 - Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers Phase 1
Completed NCT00709852 - Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging Phase 3
Terminated NCT00659776 - MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation Phase 2